Pathstone Holdings
OMGA

Pathstone Holdings’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Pathstone Holdings’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,789
Closed -$20K – 2409
2024
Q4 		$20K Sell
26,789
-14,000
-34% -$13.9K ﹤0.01% 2288
2024
Q3 		$49.8K Buy
+40,789
New +$64.9K ﹤0.01% 2293

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Pathstone Holdings's OMGA Position: Q1 2025 in Review

Pathstone Holdings sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 26,789 shares — an estimated $20K sold.

Pathstone Holdings first reported a position in OMGA in Q3 2024 and held it in 2 quarters. The position peaked at $49.8K in Q3 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Pathstone Holdings reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 26,789 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $20K.
  • Pathstone Holdings first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
  • Pathstone Holdings's Omega Therapeutics, Inc. Common Stock position peaked at $49.8K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.